Show simple item record

Characterization of host cell factors used by emerging coronaviruses for entry into target cells

dc.contributor.advisorPöhlmann, Stefan Prof. Dr.
dc.contributor.authorKleine-Weber, Hannah
dc.date.accessioned2020-07-24T10:31:24Z
dc.date.available2020-07-24T10:31:24Z
dc.date.issued2020-07-24
dc.identifier.urihttp://hdl.handle.net/21.11130/00-1735-0000-0005-1432-C
dc.identifier.urihttp://dx.doi.org/10.53846/goediss-8112
dc.language.isodeude
dc.relation.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/
dc.subject.ddc570de
dc.titleCharacterization of host cell factors used by emerging coronaviruses for entry into target cellsde
dc.typedoctoralThesisde
dc.contributor.refereePöhlmann, Stefan Prof. Dr.
dc.date.examination2020-07-14
dc.description.abstractengHuman coronaviruses (HCoV) mainly cause common cold-like symptoms. However, in the last two decades the emerging coronaviruses the severe acute respiratory syndrome coronavirus (SARS-CoV) (in 2002), Middle East respiratory syndrome coronavirus (MERS-CoV) (in 2014) and SARS-CoV-2 (in 2019) were introduced into the human population from animal reservoirs and were found to cause severe disease. Novel antiviral strategies are required to combat these viruses particularly the pandemic SARS-CoV-2, the causative agent of coronavirus disease 2019 (COVID-19). Coronaviruses harbor a spike glycoprotein (S) in their envelope, which is responsible for host cell entry. Entry depends on S protein interactions with cellular receptors and on S protein activation by host cell proteases. The goal of this thesis was to identify these interaction partners and to characterize these interactions on the molecular level, with the ultimate goal to identify targets for antiviral intervention. The thesis work revealed that MERS-CoV and SARS-CoV-2 S proteins depend on furin-mediated cleavage at the so called S1/S2 site for subsequent S protein cleavage at the S2’ site, which results in S protein activation for entry into human lung cells. Moreover, the results of this thesis show that polymorphisms in the S protein of MERS-CoV can protect the virus against antibody mediated neutralization and that polymorphisms in the viral receptor dipeptidyl peptidase 4 (DPP4), modulate entry efficiency. Finally, it was uncovered that SARS-CoV-2, like SARS-CoV, employs angiotensin-converting enzyme 2 (ACE2) and the transmembrane serine protease subtype 2 (TMPRSS2) for entry into lung cells and evidence was provided that the clinically proven TMPRSS2 inhibitor camostat mesylate could be used for COVID-19 treatment. In sum, the study provided key insights into host cell entry of MERS-CoV and SARS-CoV-2 and defined TMPRSS2 as target for interventionde
dc.contributor.coRefereeGroß, Uwe Prof. Dr.
dc.contributor.thirdRefereeWeber, Friedemann Prof. Dr.
dc.subject.engcoronavirusesde
dc.identifier.urnurn:nbn:de:gbv:7-21.11130/00-1735-0000-0005-1432-C-8
dc.affiliation.instituteGöttinger Graduiertenschule für Neurowissenschaften, Biophysik und molekulare Biowissenschaften (GGNB)de
dc.subject.gokfullBiologie (PPN619462639)de
dc.identifier.ppn1725538997


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record